New app aims to keep heart patients healthy at home

NCT ID NCT05951088

Recruiting now Symptom relief Sponsor: University Hospital, Antwerp Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a mobile app called Cardio2U for people with atrial fibrillation or heart failure. The app helps patients track their condition, learn about their disease, and communicate with their care team. Researchers will check if patients find the app easy to use and if they stick with it over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cardio2U mobile application
What this could lead to: If successful, this app could improve how heart patients manage their condition at home, potentially reducing hospital visits and boosting self-care.
What could go wrong: This is a small, early-stage study focused on usability and satisfaction, not clinical outcomes. The app may not improve health or be widely adopted.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation atrial flutter heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EDUCATION FOLLOW-UP MOBILE HEALTH

Contacts and locations

Locations

University Hospital Antwerp
RECRUITING

Edegem, Antwerp, 2650, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.